Quintrio
Home

TELEPHONE & TELEGRAPH APPARATUS

ClearOne, Inc. Common Stock

CLRO

ClearOne Inc is currently engaged in activities that consist solely of fulfilling warranty and technical support obligations on legacy products, evaluating potential Strategic Transactions, managing and liquidating remaining assets of the company's legacy operating business, collecting accounts receivable and recovering prepaid assets, satisfying outstanding liabilities, and maintaining public-company compliance.

Last trade $4.80
Day change +$0.02 (+0.42%)
Day range $4.37 – $5.15
Volume 1,069,160
Market cap $13M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$12.79M
Price / earnings
—
Price / book
-11.72×
Price / sales
—
EV / sales
—
EV / EBITDA
-4×

Profitability

Earnings per share
-$2.64
Return on assets
-1,131.94%
Return on equity
646.38%
Dividend yield
0%

Liquidity and leverage

Debt / equity
-0.94×
Current ratio
0.38×
Quick ratio
0.2×
Cash ratio
0.01×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$6.37M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for CLRO, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$0$0$0$0$0$0$0$0
Cost of revenue$27K$70K$70K$248K$27K$100K$27K$114K
Gross profit-$27K-$70K-$70K-$248K-$27K-$100K-$27K-$114K
Selling, general and administrative$763K$849K$780K$641K$827K$1.09M$799K-$722K
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$763K$849K$780K$888K$827K$1.09M$799K-$475K
Operating income-$790K-$919K-$850K-$1.14M-$854K-$1.19M-$826K$361K
Interest expense-$25K$0$0$28K-$20K-$8K$0-$264K
Income before taxes-$815K-$919K-$850K-$1.27M-$870K-$1.2M-$814K$305K
Income taxes$0$0$0$74K$1K$8K$0$69K
Net income-$709K-$914K-$487K-$4.94M-$13.74M-$4.57M-$2.83M-$2.2M
Net income attributable to common shareholders-$709K-$914K-$487K-$4.94M-$13.74M-$4.57M-$2.83M-$2.2M
EBITDA-$790K-$919K-$850K-$889K-$854K-$1.19M-$826K$608K
Basic earnings per share-$0.26-$0.34-$0.21-$2.54-$7.92-$2.64-$1.71-$1.38
Diluted earnings per share-$0.26-$0.34-$0.18-$2.54-$7.92-$2.64-$1.71-$1.38

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Medical announced a definitive merger agreement to merge its wholly owned subsidiary Cortigent, Inc. with ClearOne, Inc. Under the transaction, Cortigent will become a wholly owned subsidiary of ClearOne, which will be renamed Cortigent Holdings, Inc. and trade under ticker symbol 'CRGT'. ClearOne will raise $10-15 million in concurrent financing. Vivani will receive 12.5 million shares and own 59.4-67.5% of the combined company. The transaction is expected to close in Q3 2026.

Benzinga

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents. Fastenal shares dipped 6.7% to $69.73 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Rallybio Corporation (NASDAQ: RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rent the Runway, Inc. (NASDAQ: RENT) shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance. Eliem Therapeutics, Inc. (NASDAQ: ELYM) jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement. Akanda Corp. (NASDAQ: AKAN) gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Alpine Immune Sciences, Inc. (NASDAQ: ALPN) rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company. Candel Therapeutics, Inc. (NASDAQ: CADL) surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 26% to $24.97. Enliven Therapeutics announced proof ...

Benzinga

Nasdaq Gains Over 50 Points; US Producer Prices Increase In March

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94. The S&P 500 also rose, gaining, 0.17% to 5,169.21. Check This Out: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report   Leading and Lagging Sectors   Real estate shares rose by 0.6% on Thursday. In trading on Thursday, financial shares fell by 0.1%.   Top Headline   Producer prices in the U.S. rose 0.2% month-over-month in March compared to a 0.6% gain in February. However, analysts were expecting a gain of 0.3%.   Equities Trading UP   Rallybio Corporation (NASDAQ: RLYB) shares shot up 95% to $3.1793 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Shares of Eliem Therapeutics, Inc. (NASDAQ: ELYM) got a boost, ...

Benzinga

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rallybio shares jumped rose 77.9% to $2.90 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Rent the Runway, Inc. (NASDAQ: RENT) shares rose 40.8% to $10.42 in pre-market trading after the company reported mixed fourth-quarter financial results and issued guidance. Alpine Immune Sciences, Inc. (NASDAQ: ALPN) gained 36.1% to $64.02 in pre-market trading after Vertex entered into an agreement to acquire the company. TuanChe Limited (NASDAQ: TC) shares gained 24.4% to $2.24 in pre-market trading after falling 8% on Wednesday. Verb Technology Company, Inc. (NASDAQ: VERB) gained 18.5% to $0.2156 in pre-market trading after gaining 4% on Wednesday. Vera Therapeutics, Inc. (NASDAQ: VERA) climbed 13.1% to $47.06 in pre-market trading ...

PennyStocks

How Communities Impact Penny Stocks, 3 Ways

Here's how communities impact penny stocks in 2024 The post How Communities Impact Penny Stocks, 3 Ways appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Apr 11, 2024$7.50Apr 10, 2024special
Jun 1, 2023$15.00May 31, 2023special
Mar 6, 2018$1.05Mar 21, 2018recurring
Nov 21, 2017$1.05Dec 6, 2017recurring
Aug 18, 2017$1.05Sep 7, 2017recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jun 10, 20251-for-15reverse split